Back to Results
First PageMeta Content
Microbiology / Tuberculosis treatment / Latent tuberculosis / Isoniazid / Pyrazinamide / AIDS / Rifampicin / Directly Observed Therapy – Short Course / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Health


Recommendations for drug allocations for TB during INH shortages January 29, 2013
Add to Reading List

Document Date: 2014-07-21 13:52:24

Open Document

File Size: 73,05 KB

Share Result on Facebook

City

Princeton / Sellersville / London / Marietta / /

Company

Teva Pharmaceuticals / VersaPharm Incorporated / WHO Press / Sandoz Inc. / INH / /

Continent

America / /

Country

United States / /

Facility

Royal College of Physicians / National Institute / /

IndustryTerm

pharmaceutical / /

MedicalCondition

TB / disease / TB disease / INH- or RIFresistant M. tuberculosis / active tuberculosis / active TB / latent TB infection / tuberculosis disease / diseases / severe illness / HIV/AIDS / infection / Infectious Disease / injuries / tuberculosis / latent Mycobacterium tuberculosis infection / /

MedicalTreatment

antiretroviral treatment / Directly observed therapy / /

Organization

World Health Organization / Food and Drug Administration / CDC / Institute for Health / Centers for Disease Control and Prevention / /

Person

Joann Schaefer / /

/

Position

Chief Medical Officer / Family/Internal/General / M.D. Chief Medical Officer / /

Product

levofloxacin / pyrazinamide / INH / Isoniazid / Rifampin / /

ProvinceOrState

Nebraska / New Jersey / Pennsylvania / Georgia / /

PublishedMedium

Morbidity and Mortality Weekly Report / /

URL

http /

SocialTag